Association of the metabolic syndrome with pulmonary venous hypertension

Chest

Volumn 136, Issue 1, 2009, Pages 31-36

  Robbins, Ivan M ^a   Newman, John H ^a   Johnson, Roger F ^a   Hemnes, Anna R ^a   Fremont, Richard D ^a   Piana, Robert N ^b   Zhao, David X ^b   Byrne, Daniel W ^a  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDIABETIC AGENT; ANTIHYPERTENSIVE AGENT; HYPOCHOLESTEROLEMIC AGENT; INSULIN;

ADULT; ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DIABETES MELLITUS; DIASTOLIC DYSFUNCTION; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; HUMAN; HYPERGLYCEMIA; HYPERLIPIDEMIA; HYPERTENSION; LUNG ARTERY PRESSURE; LUNG HEMODYNAMICS; LUNG RESISTANCE; LUNG VASCULAR RESISTANCE; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; MULTIPLE SCLEROSIS; OBESITY; PREVALENCE; PRIORITY JOURNAL; PULMONARY HYPERTENSION;

EID: 67650786508     PISSN: 00123692     EISSN: 19313543     Source Type: Journal    
DOI: 10.1378/chest.08-2008     Document Type: Article

References (26)

1. Simonneau G, Galie N, Rubin LJ, et al. Clinical classification of pulmonary hypertension. J Am Coll Cardiol 2004; 43:5S-12S
2. Thompson W, White PD. Commonest cause of hypertrophy of the right ventricle-left ventricular strain and failure. Am Heart J 1936; 12:641-649
3. Bhatia RS, Tu JV, Lee DS, et al. Outcome of heart failure with preserved ejection fraction in a population-based study. N Engl J Med 2006; 355:260-269
4. Redfield MM, Jacobsen SJ, Burnett JC Jr, et al. Burden of systolic and diastolic ventricular dysfunction in the community: appreciating the scope of the heart failure epidemic. JAMA 2003; 289:194-202
5. Klapholz M, Maurer M, Lowe AM, et al. Hospitalization for heart failure in the presence of a normal left ventricular ejection fraction: results of the New York Heart Failure Registry. J Am Coll Cardiol 2004; 43:1432-1438
6. Abramson SV, Burke JF, Kelly JJ Jr, et al. Pulmonary hypertension predicts mortality and morbidity in patients with dilated cardiomyopathy. Ann Intern Med 1992; 116: 888-895
7. Braunwald E, Braunwald NS, Ross J Jr, et al. Effects of mitral-valve replacement on the pulmonary vascular dynamics of patients with pulmonary hypertension. N Engl J Med 1965; 273:509-514
8. Zener JC, Hancock EW, Shumway NE, et al. Regression of extreme pulmonary hypertension after mitral valve surgery. Am J Cardiol 1972; 30:820-826
9. Willens HJ, Kessler KM. Severe pulmonary hypertension associated with diastolic left ventricular dysfunction. Chest 1993; 103:1877-1883
10. Neuman Y, Kotliroff A, Bental T, et al. Pulmonary artery pressure and diastolic dysfunction in normal left ventricular systolic function. Int J Cardiol 2008; 127:174-178
11. Ammash NM, Seward JB, Bailey KR, et al. Clinical profile and outcome of idiopathic restrictive cardiomyopathy. Circulation 2000; 101:2490-2496
12. Bertog SC, Thambidorai SK, Parakh K, et al. Constrictive pericarditis: etiology and cause-specific survival after pericardiectomy. J Am Coll Cardiol 2004; 43:1445-1452
13. World Health Organization. Definition, diagnosis and classification of diabetes mellitus and its complications: report of a WHO consultation. Available at: http://whqlibdoc.who.int/hq/ 1999/WHO-NCD-NCS-99.2.pdf. Accessed February 23, 2009
14. Grundy SM, Brewer HB Jr, Cleeman JI, et al. Definition of metabolic syndrome: report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Circulation 2004; 109: 433-438
15. Barst RJ, McGoon M, Torbicki A, et al. Diagnosis and differential assessment of pulmonary arterial hypertension. J Am Coll Cardiol 2004; 43:40S-47S
16. Galie N, Torbicki A, Barst R, et al. Guidelines on diagnosis and treatment of pulmonary arterial hypertension: the Task Force on Diagnosis and Treatment of Pulmonary Arterial Hypertension of the European Society of Cardiology. Eur Heart J 2004; 25:2243-2278
17. Bush CA, Stang JM, Wooley CF, et al. Occult constrictive pericardial disease: diagnosis by rapid volume expansion and correction by pericardiectomy. Circulation 1977; 6:924-930
18. Humbert M, Sitbon O, Simonneau G. Treatment of pulmonary arterial hypertension. N Engl J Med 2004; 351:1425-1436
19. Freedman DS, Khan LK, Serdula MK, et al. Trends and correlates of class 3 obesity in the United States from 1990 through 2000. JAMA 2002; 14:1758-1761
20. Sturm R. Increases in morbid obesity in the USA: 2000-2005. Public Health 2007; 7:492-496
21. Ford ES, Giles WH, Dietz WH. Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. JAMA 2002; 287: 356-359
22. Wong CY, O'Moore-Sullivan T, Fang ZY, et al. Myocardial and vascular dysfunction and exercise capacity in the metabolic syndrome. Am J Cardiol 2005; 96:1686-1691
23. Masugata H, Senda S, Goda F, et al. Left ventricular diastolic dysfunction as assessed by echocardiography in metabolic syndrome. Hypertens Res 2006; 29:897-903
24. de las Fuentes L, Brown AL, Mathews SJ, et al. Metabolic syndrome is associated with abnormal left ventricular diastolic function independent of left ventricular mass. Eur Heart J 2007; 28:553-559
25. Little WC, Downes TR, Applegate RJ. Invasive evaluation of left ventricular diastolic performance. Herz 1990; 15:362-376
26. Kasner M, Westermann D, Steendijk P, et al. Utility of Doppler echocardiography and tissue Doppler imaging in the estimation of diastolic function in heart failure with normal ejection fraction: a comparative Doppler-conductance catheterization study. Circulation 2007; 116:637-647